Published on in Children's Doctor
Dr. Marni Falk provides an overview of the field of mitochondrial medicine and the role of CHOP's Mitochondrial Medicine Frontier Program in advancing research and care.
Published on in Children's Doctor
Using the case of a 24-month-old African-American boy, Drs. Ganetzky and Goldstein discuss sideroblastic anemia and how it might be an indicator for multisystem mitochondrial disease.
Published on in Children's Doctor
Dr. Cunningham writes about when and why should a muscle biopsy be considered in the evaluation of mitochondrial disease, and how to obtain a muscle biopsy.
Published on in CHOP News
6ABC shows how one family is making a difference for mitochondrial medicine at Children's Hospital of Philadelphia.
Published on in CHOP News
As clinical trials aim to attain the first FDA-approved treatments for mitochondrial disease, a study reports patient and family preferences.
Published on in CHOP News
Systematic laboratory studies find some antioxidants should be tested in clinical trials as treatments for patients with mitochondrial disease.
Published on in CHOP News
Lacking effective drug treatments, patients with mitochondrial disease may use many vitamins and supplements — most of which are unregulated and untested.
Published on in CHOP News, International Update
Physicians who see patients with mitochondrial disease have a practical new tool: the first published care standards to guide clinical care.
Published on in CHOP News
CHOP’s Douglas Wallace, a world-renowned pioneer in mitochondrial biology, received the 2017 Benjamin Franklin Medal in Life Science at the Franklin Institute.
Published on in CHOP News
Using lithium and other drugs in cell and animal models, CHOP researchers may have broken a logjam in devising effective treatments for mitochondrial diseases.